DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP SOLUTION Canada - English - Health Canada

dopamine hcl 3.2mg/ml dextrose 5% inj usp solution

baxter corporation - dopamine hydrochloride; dextrose - solution - 3.2mg; 50mg - dopamine hydrochloride 3.2mg; dextrose 50mg - selective beta 1-adrenergic agonists

DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP SOLUTION Canada - English - Health Canada

dopamine hcl 1.6mg/ml dextrose 5% inj usp solution

baxter corporation - dopamine hydrochloride; dextrose - solution - 1.6mg; 50mg - dopamine hydrochloride 1.6mg; dextrose 50mg - selective beta 1-adrenergic agonists

DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP SOLUTION Canada - English - Health Canada

dopamine hcl 0.8mg/ml dextrose 5% inj usp solution

baxter corporation - dopamine hydrochloride; dextrose - solution - 0.8mg; 50mg - dopamine hydrochloride 0.8mg; dextrose 50mg - selective beta 1-adrenergic agonists

Dopamine Hydrochloride 400mg/250mL (1.6mg/mL) Dextrose Injection Philippines - English - FDA (Food And Drug Administration)

dopamine hydrochloride 400mg/250ml (1.6mg/ml) dextrose injection

baxter healthcare phils inc - dopamine hydrochloride - dextrose injection - 400mg/250ml (1.6mg/ml)

DBL™ Sterile Dopamine Concentrate New Zealand - English - Medsafe (Medicines Safety Authority)

dbl™ sterile dopamine concentrate

pfizer new zealand limited - dopamine hydrochloride 40 mg/ml;   - solution for injection - 200 mg/5ml - active: dopamine hydrochloride 40 mg/ml   excipient: sodium metabisulfite water for injection - latest regulatory activity

Sterile Dopamine concentrate BP New Zealand - English - Medsafe (Medicines Safety Authority)

sterile dopamine concentrate bp

max health limited - dopamine hydrochloride 40 mg/ml - solution for injection - 200 mg/5ml - active: dopamine hydrochloride 40 mg/ml excipient: hydrochloric acid nitrogen sodium hydroxide sodium metabisulfite water for injection - for the correction of haemodynamic imbalance present in: acute hypotension or shock associated with myocardial infarction, endotoxic septicaemia, trauma and renal failure. as an adjunct after open heart surgery, where there is persistent hypotension after correction of hypovolaemia. in chronic cardiac decompensation as in congestive failure.